SIGN UP

Sign up to get updates about our clinical trials and other exciting news close

A FOCUS ON THOSE WHO HAVE FEW OPTIONS

People with rare, difficult-to-treat or advanced forms of cancer may have few treatment options. This can make the future feel uncertain.

Idera is committed to cancer research and investigating new medicines that have the potential to improve lives. Through this research, we also seek to contribute to the understanding of disease and the advancement of patient care, in collaboration with leading scientists and clinicians.

A FOCUS ON THOSE WHO HAVE FEW OPTIONS

People with rare, difficult-to-treat or advanced forms of cancer may have few treatment options. This can make the future feel uncertain.

Idera is committed to cancer research and investigating new medicines that have the potential to improve lives. Through this research, we also seek to contribute to the understanding of disease and the advancement of patient care, in collaboration with leading scientists and clinicians.

In the Illuminate clinical trials, researchers are evaluating an investigational drug called tilsotolimod (IMO-2125) to help treat patients with metastatic melanoma and other types of cancer.

What is tilsotolimod?

Tilsotolimod is an investigational drug. That means it has not been approved for use by any regulatory agency, such as the US Food and Drug Administration (FDA).

Tilsotolimod is thought to work by helping to stimulate your body’s immune system to target and identify cancer cells in your body.

Based on early research, it is believed that tilsotolimod may provide more effective tumor control when combined with other drugs called immunotherapy drugs.

Immunotherapy refers to a type of treatment that boosts a person’s own immune system to help fight diseases, including cancer.

Tilsotolimod is given as an injection directly into the tumor.

MELANOMA IS A TYPE OF SKIN CANCER THAT OCCURS IN MELANOCYTES, THE CELLS THAT COLOR THE SKIN AND MAKE MOLES.

It is the most serious type of skin cancer because it can spread or metastasize to other tissues and organs in the body. Metastatic melanoma often spreads to the tissue under the skin, lymph nodes, lungs, liver and brain. Recent advances in treatment have significantly extended survival in some patients with metastatic melanoma. However, new treatments are still urgently needed to help more patients control their disease.

For more information about metastatic melanoma, please visit: